Myelodysplastic Syndromes (MDS) News

Luspatercept Eyes Treatment of Anemia in Low-Risk MDS - Medscape



Medscape
 
Luspatercept Eyes Treatment of Anemia in Low-Risk MDS 
Medscape
Myelodysplastic syndromes (MDS) ? clonal stem-cell disorders ? are characterized by anemia and a risk for transformation to leukemia. A mainstay of treatment in low-risk or intermediate-risk patients (defined by the International Prognostic Scoring ...

 


Toddler to get bone marrow transplant - Revelstoke Review



Revelstoke Review
 
Toddler to get bone marrow transplant 
Revelstoke Review
At the Vancouver hospital Alice was soon diagnosed with one of the cancers known as myelodysplastic syndromes (MDS) that is not normally seen in children. Pasemko, a retired educational assistant at Red Deer's Eastview Middle School, said her former ...

and more » 


Increase in Diagnosis Rate is Expected to Surge the Myelodysplastic Syndrome Treatment market to US $ 5.7 bn 2025 - Industry Today (press release)



Increase in Diagnosis Rate is Expected to Surge the Myelodysplastic Syndrome Treatment market to US $ 5.7 bn 2025 
Industry Today (press release)
Myelodysplastic syndrome (MDS) refers to the closely related group of hematopoietic clonal disorders that are majorly observed among the geriatric population. The myelodysplastic syndromes rarely exhibit any symptoms during their earlier stages.

 


Glynn Moore: My leukemia gave way to MDS, with its own treatment ahead - The Augusta Chronicle



The Augusta Chronicle
 
Glynn Moore: My leukemia gave way to MDS, with its own treatment ahead 
The Augusta Chronicle
My oncologist, Dr. Brent Limbaugh, conferred with a colleague on a business trip and diagnosed something I had never heard of before: myelodysplastic syndrome. That's MDS to you and me. It's a cancer that contorts the shape of the newly minted blood ...

 


Onconova Therapeutics to Present Updates at Two Investor Conferences in October - GlobeNewswire (press release)



Finance News Daily
 
Onconova Therapeutics to Present Updates at Two Investor Conferences in October 
GlobeNewswire (press release)
Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with a primary focus on Myelodysplastic Syndromes (MDS). Rigosertib, Onconova's ...
Onconova up 18% on positive Phase 3 outlook on lead candidate rigosertib Seeking Alpha
Here's What's Moving Onconova Therapeutics Inc (NASDAQ:ONTX) and Amgen (NASDAQ:AMGN) Market Exclusive
Onconova Therapeutics, Inc. (NASDAQ:ONTX) Signals Intraday Volatility ? Up $0.90 First News 24

all 63 news articles » 


Financial Review: Onconova Therapeutics (ONTX) versus Auxilium Pharmaceuticals (AUXL) - TrueBlueTribune



Financial Review: Onconova Therapeutics (ONTX) versus Auxilium Pharmaceuticals (AUXL) 
TrueBlueTribune
... rigosertib, is being tested in both intravenous (IV) and oral formulations as a single agent, and the oral formulation is also being tested in combination with azacitidine, in clinical trials for patients with myelodysplastic syndromes (MDS), and ...

and more » 


Genetic fault that reduces the effectiveness of leukemia treatment ... - Science Daily



Genetic fault that reduces the effectiveness of leukemia treatment ... 
Science Daily
A genetic fault has been identified in people with an aggressive type of leukemia that can significantly affect how they respond to treatment, report investigators.

and more » 


FibroGen (FGEN) Reports China FDA Acceptance of Roxadustat New Drug Application (NDA) - StreetInsider.com



FibroGen (FGEN) Reports China FDA Acceptance of Roxadustat New Drug Application (NDA) 
StreetInsider.com
... the Middle East, and South Africa. In the next stage of its development program, roxadustat is entering a Phase 2/3 clinical trial in China and a Phase 3 clinical trial in the U.S. for the treatment of anemia in patients with myelodysplastic ...

and more » 


Robin Roberts gives keynote address at UR's Meliora Weekend - Rochester Democrat and Chronicle



Rochester Democrat and Chronicle
 
Robin Roberts gives keynote address at UR's Meliora Weekend 
Rochester Democrat and Chronicle
TV personality's Robin Roberts and Trevor Noah come to Rochester for RIT and University of Rochester's' homecoming weekends.

and more » 


Protagonist Therapeutics Announces Preliminary Phase 1 Study ... - Markets Insider



Protagonist Therapeutics Announces Preliminary Phase 1 Study ... 
Markets Insider
NEWARK, Calif., Sept. 20, 2017 /PRNewswire/ -- Protagonist Therapeutics, Inc. (Nasdaq: PTGX) today announced preliminary results from the Phase 1 study of ...

and more »